|
Factsheet as on April 30, 2026 |
To generate long-term capital appreciation from a diversified portfolio of predominantly equity & equity related instruments of small cap companies. There is no assurance that the investment objective of the Scheme will be achieved.

| 1 Year | 2 Years | 3 Years | 5 Years | |
| Scheme (%) | 8.45 | 7.66 | 17.83 | 18.11 |
| BSE 200 (%) | 11.40 | 8.53 | 23.25 | 20.06 |
| Company Name | % of Assets |
| CCL Products (I) Ltd. | 2.8 |
| Nifty | 2.7 |
| Krishna Institute of Medical Sciences Ltd. | 2.5 |
| JB Chemicals & Pharmaceuticals Ltd. | 2.2 |
| Multi Commodity Exchange of India Ltd. | 2.2 |
| City Union Bank Ltd. | 1.9 |
| Brigade Enterprises Ltd. | 1.8 |
| Bank Nifty | 1.8 |
| Blue Star Ltd. | 1.6 |
| Cholamandalam Financial Holdings Ltd. | 1.6 |

| Standard Deviation | 15.01 |
| Beta | 1.00 |
| Information Ratio | 0.16 |
| Sharpe Ratio | 0.33 |


Kotak Mahindra Bank Limited, AMFI Registered Mutual Fund Distributor, ARN 1390
Kotak Mahindra Bank Limited, AMFI Registered Mutual Fund Distributor, ARN 1390